Literature DB >> 24827766

Clinical severity scores in gastrointestinal graft-versus-host disease.

Julie Abraham1, Anne Janin, Jean-Marc Gornet, Régis Peffault de Latour, Marie Robin, Aliénor Xhaard, Flore Sicre de Fontebrune, Jean Yves Mary, Matthieu Allez, Raphael Porcher, Gérard Socié.   

Abstract

BACKGROUND: The clinical prognosis of gastrointestinal (GI) graft-versus-host disease (GvHD) is based on either a clinical staging system or histological or endoscopic findings. How these different scores correlate with each other and which have the greater impact on transplantation outcomes is, however, not clear.
METHODS: Clinical, pathological, and endoscopic findings of the upper GI tract on 201 patients who underwent allogeneic hematopoietic stem cell transplantation were reviewed. The association between clinical, histological, and endoscopy grading was assessed by Kendall correlation coefficient. The agreement between grading systems was evaluated by kappa statistics. Factors associated with survival or steroid resistance were analyzed by proportional hazard models.
RESULTS: At disease onset, no strong association was found between pathological and clinical grade at disease onset (τ=0.034, P=0.6). In contrast, endoscopy score and clinical grades were strongly associated (τ=0.37, P<0.001). The Kappa concordance coefficient (0.20) between histological and endoscopy scores was poor. However, by multivariate analysis all three scores significantly predicted survival rates
CONCLUSIONS: Clinical, histological, and endoscopic scores poorly correlated with each other when estimated at the GI-GvHD onset. However, all three severe initial scores independently predict poor outcome. Of interest, clinical and endoscopic scores predict resistance to steroids while pathological does not.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24827766     DOI: 10.1097/01.TP.0000438209.50089.60

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity.

Authors:  Mathilde Payen; Ioannis Nicolis; Marie Robin; David Michonneau; Johanne Delannoye; Camille Mayeur; Nathalie Kapel; Béatrice Berçot; Marie-José Butel; Jérôme Le Goff; Gérard Socié; Clotilde Rousseau
Journal:  Blood Adv       Date:  2020-05-12

2.  NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

Authors:  Howard M Shulman; Diana M Cardona; Joel K Greenson; Sangeeta Hingorani; Thomas Horn; Elisabeth Huber; Andreas Kreft; Thomas Longerich; Thomas Morton; David Myerson; Victor G Prieto; Avi Rosenberg; Nathaniel Treister; Kay Washington; Mirjana Ziemer; Steven Z Pavletic; Stephanie J Lee; Mary E D Flowers; Kirk R Schultz; Madan Jagasia; Paul J Martin; Georgia B Vogelsang; David E Kleiner
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-29       Impact factor: 5.742

3.  The eukaryotic gut virome in hematopoietic stem cell transplantation: new clues in enteric graft-versus-host disease.

Authors:  Jérôme Legoff; Matthieu Resche-Rigon; Jerome Bouquet; Marie Robin; Samia N Naccache; Séverine Mercier-Delarue; Scot Federman; Erik Samayoa; Clotilde Rousseau; Prescillia Piron; Nathalie Kapel; François Simon; Gérard Socié; Charles Y Chiu
Journal:  Nat Med       Date:  2017-07-31       Impact factor: 53.440

4.  Graft-versus-Host Disease of the Gut: A Histologic Activity Grading System and Validation.

Authors:  David Myerson; Gideon Steinbach; Ted A Gooley; Howard M Shulman
Journal:  Biol Blood Marrow Transplant       Date:  2017-05-19       Impact factor: 5.742

5.  TNFAIP8 Deficiency Exacerbates Acute Graft Versus Host Disease in a Murine Model of Allogeneic Hematopoietic Cell Transplantation.

Authors:  Reena Kumari; Senthilnathan Palaniyandi; Ethan Strattan; Timothy Huang; Katharina Kohler; Nashwan Jabbour; Joanna Dalland; Jing Du; Melissa V Kesler; Youhai H Chen; Gerhard C Hildebrandt
Journal:  Transplantation       Date:  2020-03       Impact factor: 4.939

6.  How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver.

Authors:  George B McDonald
Journal:  Blood       Date:  2016-01-04       Impact factor: 22.113

7.  Favourable survival in "Discordant" acute gastrointestinal graft versus host disease (GI-GVHD) is explained by mild clinical course and treatment-responsive disease.

Authors:  Ashleigh P Scott; Caitlin Thirunavukarasu; Glen A Kennedy; Siok-Keen Tey
Journal:  Int J Hematol       Date:  2020-01-07       Impact factor: 2.490

8.  Consensus diagnostic histopathological criteria for acute gastrointestinal graft versus host disease improve interobserver reproducibility.

Authors:  Andreas Kreft; Anja Mottok; Ildiko Mesteri; Diana M Cardona; Anne Janin; Anja A Kühl; Mindaugas Andrulis; Andrea Brunner; Howard M Shulman; Giovanni Negri; Alexandar Tzankov; Elisabeth Huber
Journal:  Virchows Arch       Date:  2015-07-12       Impact factor: 4.064

9.  Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment.

Authors:  George B McDonald; Laura Tabellini; Barry E Storer; Richard L Lawler; Paul J Martin; John A Hansen
Journal:  Blood       Date:  2015-05-18       Impact factor: 22.113

10.  International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.

Authors:  Andrew C Harris; Rachel Young; Steven Devine; William J Hogan; Francis Ayuk; Udomsak Bunworasate; Chantiya Chanswangphuwana; Yvonne A Efebera; Ernst Holler; Mark Litzow; Rainer Ordemann; Muna Qayed; Anne S Renteria; Ran Reshef; Matthias Wölfl; Yi-Bin Chen; Steven Goldstein; Madan Jagasia; Franco Locatelli; Stephan Mielke; David Porter; Tal Schechter; Zhanna Shekhovtsova; James L M Ferrara; John E Levine
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-16       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.